Jiangxue Wu

1.4k total citations
34 papers, 1.1k citations indexed

About

Jiangxue Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiangxue Wu has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Jiangxue Wu's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Virus-based gene therapy research (4 papers). Jiangxue Wu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Virus-based gene therapy research (4 papers). Jiangxue Wu collaborates with scholars based in China, United States and Hong Kong. Jiangxue Wu's co-authors include Wenlin Huang, Ranyi Liu, Xiaofang Ying, Xiangqi Meng, Changchuan Pan, Zhizhong Pan, Yi Zhou, Yufang Zuo, Hongyan Yu and Hui Wang and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Jiangxue Wu

34 papers receiving 1.1k citations

Peers

Jiangxue Wu
T J Collard United Kingdom
Marten Hornsveld Netherlands
Nora D. Mineva United States
Sara Kubek United States
Yang W. Zhang United States
Hitomi Saso United States
Hee‐Jun Wee South Korea
Zdeněk Andrysík United States
T J Collard United Kingdom
Jiangxue Wu
Citations per year, relative to Jiangxue Wu Jiangxue Wu (= 1×) peers T J Collard

Countries citing papers authored by Jiangxue Wu

Since Specialization
Citations

This map shows the geographic impact of Jiangxue Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangxue Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangxue Wu more than expected).

Fields of papers citing papers by Jiangxue Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangxue Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangxue Wu. The network helps show where Jiangxue Wu may publish in the future.

Co-authorship network of co-authors of Jiangxue Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangxue Wu. A scholar is included among the top collaborators of Jiangxue Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangxue Wu. Jiangxue Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lili, Deming Li, Jiangxue Wu, et al.. (2023). Lactoferrin alleviates Western diet-induced cognitive impairment through the microbiome-gut-brain axis. Current Research in Food Science. 7. 100533–100533. 17 indexed citations
2.
Qiu, Lin, et al.. (2022). CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma. Frontiers in Oncology. 12. 774458–774458. 11 indexed citations
3.
Li, Yunhong, Jiangxue Wu, He Qian, et al.. (2022). Amelioration of radiation-induced liver damage by p-coumaric acid in mice. Food Science and Biotechnology. 31(10). 1315–1323. 7 indexed citations
4.
Wu, Jiangxue, Shuai Chen, Ranyi Liu, et al.. (2018). SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter. Cancer Letters. 422. 56–69. 42 indexed citations
5.
Tan, Xin, Shuai Chen, Jiangxue Wu, et al.. (2017). PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407. Cell Death and Disease. 8(3). e2686–e2686. 74 indexed citations
6.
Geng, Rong, Xin Tan, Zhixiang Zuo, et al.. (2017). Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells. Chinese Journal of Cancer. 36(1). 63–63. 10 indexed citations
7.
Lin, Jiaxin, Xin Tan, Lin Qiu, et al.. (2017). Long Noncoding RNA BC032913 as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3. Molecular Therapy — Nucleic Acids. 8. 469–481. 23 indexed citations
8.
Yu, Hongyan, Wen Ye, Jiangxue Wu, et al.. (2014). Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer. Clinical Cancer Research. 20(13). 3434–3445. 115 indexed citations
9.
Ye, Wen, Ranyi Liu, Changchuan Pan, et al.. (2014). Multicenter Randomized Phase 2 Clinical Trial of a Recombinant Human Endostatin Adenovirus in Patients with Advanced Head and Neck Carcinoma. Molecular Therapy. 22(6). 1221–1229. 36 indexed citations
10.
Zhou, Yi, Jiangxue Wu, Xiang Fu, et al.. (2014). OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Molecular Cancer. 13(1). 258–258. 82 indexed citations
11.
Meng, Xiangqi, Jiangxue Wu, Changchuan Pan, et al.. (2013). Genetic and Epigenetic Down-regulation of MicroRNA-212 Promotes Colorectal Tumor Metastasis via Dysregulation of MnSOD. Gastroenterology. 145(2). 426–436.e6. 103 indexed citations
12.
Ying, Xiaofang, Jiangxue Wu, Xiangqi Meng, et al.. (2013). AC133 expression associated with poor prognosis in stage II colorectal cancer. Medical Oncology. 30(1). 356–356. 13 indexed citations
13.
Han, Hongyu, Caiyun Zhong, Xu‐Chao Zhang, et al.. (2010). Genistein Induces Growth Inhibition and G2/M Arrest in Nasopharyngeal Carcinoma Cells. Nutrition and Cancer. 62(5). 641–647. 20 indexed citations
14.
Wu, Jiangxue, Xia Xiao, Hongyun Jia, et al.. (2009). Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector. BMC Cancer. 9(1). 55–55. 7 indexed citations
15.
Zhao, Peng, Rongcheng Luo, Jiangxue Wu, et al.. (2008). E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases. Journal of Cellular and Molecular Medicine. 14(1-2). 381–391. 10 indexed citations
16.
Li, Tan, Hongyun Jia, Ranyi Liu, et al.. (2008). Inhibition of NF-κB in fusogenic membrane glycoprotein causing HL-60 cell death: Implications for acute myeloid leukemia. Cancer Letters. 273(1). 114–121. 7 indexed citations
17.
Liang, Zhihui, Jiangxue Wu, Jialing Huang, et al.. (2007). Bioactivity and stability analysis of endostatin purified from fermentation supernatant of 293 cells transfected with Ad/rhEndo. Protein Expression and Purification. 56(2). 205–211. 8 indexed citations
18.
Xiao, Xia, Jiangxue Wu, Xiao‐Feng Zhu, et al.. (2007). Induction of cell cycle arrest and apoptosis in human nasopharyngeal carcinoma cells by ZD6474, an inhibitor of VEGFR tyrosine kinase with additional activity against EGFR tyrosine kinase. International Journal of Cancer. 121(9). 2095–2104. 29 indexed citations
19.
Wu, Jiangxue, Xia Xiao, Gang Xue, et al.. (2006). Minicircle-IFNγ Induces Antiproliferative and Antitumoral Effects in Human Nasopharyngeal Carcinoma. Clinical Cancer Research. 12(15). 4702–4713. 33 indexed citations
20.
Wu, Jiangxue, et al.. (2005). Expression and purification of human endostatin from Hansenula polymorpha A16. Protein Expression and Purification. 42(1). 12–19. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026